查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439666

可吸收止血劑 - 全球市場回顧、競爭格局、市場預測（2030）

Absorbable Hemostats - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

在預測期（2024-2030年），全球可吸收止血劑市場規模預計將以 6.47% 的複合年增長率成長。 由於脊椎疾病盛行率上升、手術期間患者出血控制日益受到關注以及產品開發中的技術創新等因素，該市場呈現正增長，導致2024-2030年預測期內吸收量增加。止血劑市場。

可吸收止血劑市場動態

由於各種原因，可吸收止血劑市場的產品需求不斷增長，影響市場成長的主要因素之一是脊椎疾病盛行率的上升。

根據世界衛生組織 (WHO) 的數據，2020 年全球約有 17.1 億人可能患有肌肉骨骼疾病。

上述資料顯示，2020年，腰痛是肌肉骨骼疾病中負擔最大的，全球患有此病的人數達5.68億人。

根據世界衛生組織 (WHO) (2022) 的數據，肌肉骨骼疾病是全球殘疾的主要原因，而腰痛是 160 個國家/地區殘疾的主要原因。

此外，交通事故和跌倒等創傷的增加更有可能導致脊椎損傷，進一步增加了對可吸收止血劑的需求。

根據世界衛生組織（WHO）（2022）發佈的數據，全球每年有25萬至50萬人遭受脊髓損傷（SCI），其中大部分脊髓損傷是由交通事故造成的。

此外，根據Nogo Inhibition in Spinal Cord Injury的數據，2020年歐盟每年將新增約10,000例脊髓損傷病例，按正常預期壽命計算，2020年將有超過200,000名患者遭受脊髓損傷。歐盟，承受損害。

因此，由於上述因素，全球對能夠使運動損傷和脊髓疾病早期恢復的可吸收止血劑的需求不斷增加，導致全球可吸收止血劑市場的整體增長。

因此，所有上述因素都預測可吸收止血劑在未來幾年的擴張，並有助於可吸收止血劑市場在 2024-2030 年預測期內的增長。

然而，缺乏熟練使用可吸收止血劑的專業人員以及可吸收止血劑的高成本可能是可吸收止血劑市場增長的一定限制因素。

史無前例的 COVID-19 爆發對可吸收止血劑市場產生了重大影響。 在 COVID-19 大流行期間，封鎖規定減少了患者就診次數，並暫時中止了所有其他外科手術，以確保更多關注 COVID-19 患者。確實如此。 但各類疫苗的上市已恢復正常運行，帶動了疫情後可吸收止血劑市場的成長。

可吸收止血劑細分市場分析

在可吸收止血劑市場的製劑領域，預計在 2024-2030 年預測期內，基質凝膠止血劑將佔可吸收止血劑市場的主要佔有率。 這可能是由於它在手術過程中能夠適應傷口輪廓並填充深層病變。

Matrix已被證明是一種更有效的止血劑，與其他止血劑相比，顯示出更快的止血速度和更好的治療效果。

此外，研究表明，使用基質凝膠止血劑可以減少術後併發症、減少再次手術、減少輸血和縮短手術時間。

此外，各種形式的明膠的重要特性是它們能夠吸收超過自身重量 40 倍的血液和體液，並且能夠在體內體積膨脹 200%。 這意味著明膠形式比基於膠原蛋白或再生氧化纖維素的局部止血劑增加的體積更多。

因此，基質凝膠止血劑比其他製劑製劑更優越。 因此，所有上述因素都可能在預測期內推動可吸收止血劑市場中基質凝膠類別的成長。

本報告研究和分析了全球可吸收止血劑市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第1章可吸收止血器市場報告簡介

第2章可吸收止血劑市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估
  • 財務基準

第3章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章可吸收止血劑市場主要因素分析

  • 推動可吸收止血劑市場的因素
    • 脊椎疾病的盛行率不斷上升
    • 越來越關注手術期間病患的出血控制
    • 產品開發中的技術創新
  • 可吸收止血劑市場的限制與挑戰
    • 缺乏熟練使用可吸收止血產品的專業人員
    • 可吸收止血劑成本高
  • 可吸收止血劑市場機會
    • 生物外科可吸收止血產品越來越受歡迎
    • 推出針對新興市場的產品

第5章可吸收止血劑市場波特五力分析

第6章COVID-19對可吸收止血劑市場的影響分析

第7章可吸收止血劑市場佈局

  • 依類型
    • 基於凝血酶的止血劑
    • 氧化再生纖維素系止血劑
    • 明膠止血劑
    • 膠原蛋白止血劑
    • 其他
  • 按配方劑
    • 基質凝膠止血劑
    • 海綿止血鉗
    • 粉末止血劑
  • 依用途
    • 顱神經外科
    • 骨科手術
    • 一般外科
    • 重建手術
  • 按最終用戶
    • 醫院、診所
    • 門診手術中心
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第8章可吸收止血劑市場：全球公司佔有率分析 - 3至5家主要公司

第9章可吸收止血劑市場公司及產品概況

  • B.Braun
  • Baxter
  • Johnson & Johnson
  • BD
  • Cura Medical
  • GELITA MEDICAL
  • Curasan AG
  • Meril Life Sciences
  • Zhonghui Shengxi
  • Beijing Datsing Bio-tech
  • Guizhou Jin Jiu Biotech
  • Beijing Taikesiman
  • Foryou Medical
  • Saikesaisi Holdings Group
  • Biotemed
  • Hangzhou Singclean Medical Products
  • Teleflex Incorporated
  • Hemostasis, LLC
  • Stryker
  • Samyang Holdings Corporation

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

Product Code: DIMDCL0506

Absorbable Hemostats Market By Type (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Others), By Formulants (Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, Others), By Application (Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising incidence of spinal ailments and rapid technological developmental activities in product arena

Global absorbable hemostats market is expected to grow at a CAGR of 6.47% during the forecast period (2024-2030). The absorbable hemostats market is witnessing positive growth owing to the factors such as rising incidence of spinal ailments, rising focus on blood loss management in patients during surgeries, technological innovation in product development, thereby contributing to the growth of the Absorbable Hemostats market during the forecast period from 2024-2030.

Absorbable Hemostats Market Dynamics:

The Absorbable Hemostats market is witnessing a growth in product demand owing to various reasons, one of the major factors influencing the growth of the absorbable hemostats market is the rising incidence of spinal ailments.

According to the World Health Organization 2022, in 2020 approximately 1.71 billion people tend to suffer from musculoskeletal conditions worldwide.

Report Metrics

Details

Study Period

2021 to 2030

Base Year

2022

Forecast Period

2024 to 2030

CAGR

6.47%

Market Size

--

Key Companies

B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, and others

As per the aforementioned source, in the year 2020 among musculoskeletal disorders, lower back pain had caused the highest-burden with a prevalence of 568 million people worldwide.

According to the World Health Organization 2022, musculoskeletal conditions are a leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries.

Moreover, a rise in traumatic injuries due to road crashes falls, and others are likely to cause spine injuries which will further increase the demand for Absorbable Hemostats.

As per the data published by the World Health Organization 2022, every year between 250,000 and 500,000 people suffer a spinal cord injury (SCI) around the world and the majority of spinal cord injuries are due to road traffic crashes, falls, or violence.

Additionally, the Nogo Inhibition in Spinal Cord Injury, in the year 2020, the incidence of spinal cord injury is about 10'000 newly injured people per year in the EU, and due to a normal life expectancy, more than 200,000 patients are living with a spinal cord injury in the EU.

Therefore, owing to the abovementioned factors, there is a growing need for absorbable hemostats in the market globally which allows faster recovery of sports-related injuries and spinal ailments, thereby leading to the overall growth of the global absorbable hemostats market.

Hence, all the above-mentioned factors are projected to augment for Absorbable Hemostats in the forthcoming years, thereby contributing to the growth of the Absorbable Hemostats market during the forecast period from 2024-2030.

However, the dearth of skilled professionals for effective use of absorbable hemostat products and the high cost of the absorbable hemostats may be certain limiting factors of the Absorbable Hemostats market growth.

The unprecedented COVID-19 outbreak had a profound impact on the market for absorbable hemostats. Owing to the lockdown restrictions posed during the COVID-19 pandemic, there were reduced patient visits and all other surgical procedures were temporarily paused, giving more attention to the COVID-19 inflicted patient. However, the launch of various vaccines has resumed normal operations further leading to the growth of the Absorbable Hemostats market during the post-pandemic.

Absorbable Hemostats Market Segment Analysis:

Absorbable Hemostats Market By Type (Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Others), By Formulants (Matrix & Gel Hemostats, Sponge Hemostats, Powder Hemostats, Others), By Application (Neurosurgery, Orthopedic Surgery, General Surgery, Reconstructive Surgery, Others), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Formulants segment of the Absorbable Hemostats market, the Matrix & Gel Hemostats are estimated to hold a significant share in the Absorbable Hemostats market during the forecast period from 2024-2030. This can be attributed to the fact that in surgery, they can conform to wound contours and fill deep lesions.

The matrix is proven to be a more effective hemostat, demonstrating faster hemostasis and better outcomes compared with other formulants of hemostatic agents.

Moreover, research also indicates that the use of Matrix & Gel Hemostats is associated with fewer post-surgical complications, surgical revisions, and blood transfusions, as well as shorter surgical times.

Furthermore, an important property of the different forms of gelatin is its ability to absorb more than 40 times its weight in blood and fluids and its ability to expand its volume by 200% in vivo. This means that gelatin forms increase their volume more than the topical hemostatics based on collagen and regenerated oxidized cellulose.

Therefore, the advantages associated with Matrix & Gel Hemostats compared to other formulants. Thus, all the aforementioned factors are likely to propel the matrix & gels category growth in the absorbable hemostats market during the forecast period.

North America is expected to dominate the overall Absorbable Hemostats Market:

Among all the regions, North America is expected to account for the largest share in the Global Absorbable Hemostats market. The growing number of spine-related disorders among others will also increase the absorbable hemostats market in the United States.

Further, the rising adoption of Absorbable Hemostats in the country would result in the rising demand for treatments that make use of Absorbable Hemostats, which in turn would provide a conducive growth environment for the United States Absorbable Hemostats market as well as the North American region.

For instance, the National Spinal Cord Injury Statistical Center 2019, the United States population size of 328 million people worldwide. Also, the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the United States, or about 17,730 new SCI cases each year.

Furthermore, according to the Miami Project 2020, in the year 2020, approximately 17,810 new spinal cord injuries each year in the US. Also, as per the aforementioned source, males account for about 78% of the new spinal cord injuries cases.

A rising focus on blood loss management in patients during surgeries will lead to an increase in the demand for absorbable hemostats, thereby leading to traction in the overall absorbable hemostats market.

Moreover, product approvals pertaining to absorbable hemostats will also lead to an increase in the demand for absorbable hemostats, thereby leading to an overall increase in the absorbable hemostat market.

For instance, on February 23, 2022, FDA had approved EndoClot® Hemostat to Manage GI Bleeding. EndoClot® PHS is a single-use device including a starch-based powder hemostat that is applied directly to the bleeding site through a flexible endoscope.

Thus, the interplay of all the aforementioned factors is likely to fuel the market growth of absorbable hemostats in the United States during the forecast period.

Furthermore, the increased emphasis on product development activities and the high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Absorbable Hemostats. Also, advanced product launches and commercialization agreements among the key companies are further expected to fuel the market.

Thus, the interplay of all the aforementioned factors is likely to fuel the regional market for Absorbable Hemostats during the forecasted period.

Absorbable Hemostats Market Key Players:

Some of the key market players operating in the Absorbable Hemostats market include B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products, Teleflex Incorporated, Hemostasis, LLC, Stryker, Samyang Holdings Corporation, and others.

Recent Developmental Activities in the Absorbable Hemostats Market:

On March 25, 2020, Ethicon, part of the Johnson & Johnson Medical Devices Companies, announced the strategic regional launch of SURGICEL® POWDER ABSORBABLE HEMOSTAT in Australia, New Zealand, and Thailand.

On January 09, 2018, Ethicon announced the US launch of SURGICEL® POWDER ABSORBABLE HEMOSTAT, a powdered adjunctive hemostat that was designed to help surgeons control disruptive bleeding more efficiently.

Key Takeaways from the Absorbable Hemostats Market Report Study

Market size analysis for current Absorbable Hemostats market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Absorbable Hemostats market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global Absorbable Hemostats market.

Various opportunities available for the other competitor in the Absorbable Hemostats market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Absorbable Hemostats market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Absorbable Hemostats market growth in the coming future?

Target Audience who can be benefited from this Absorbable Hemostats Market Report Study

Absorbable Hemostats products providers

Research organizations and consulting companies

Absorbable Hemostats-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Absorbable Hemostats

Various End-users who want to know more about the Absorbable Hemostats market and latest technological developments in the Absorbable Hemostats market.

Frequently Asked Questions for Absorbable Hemostats Market:

1. What are Absorbable Hemostats?

Absorbable Hemostats are used adjunctively in surgical procedures to assist in the control of capillary, venous, and small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective.

2. What is the market for Global Absorbable Hemostats?

Global absorbable hemostats market is expected to grow at a CAGR of 6.47% during the forecast period (2024-2030).

3. What are the drivers for Global Absorbable Hemostats Market?

The Absorbable Hemostats market is witnessing a positive market growth owing to the factors such as rising incidence of spinal ailments, rising focus on blood loss management in patients during surgeries, technological innovation in product development.

4. Who are the key players operating in the Global Absorbable Hemostats Market?

Some of the key market players operating in the Absorbable Hemostats market include B.Braun, Baxter, Johnson & Johnson, BD, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products, Teleflex Incorporated, Hemostasis, LLC, Stryker, Samyang Holdings Corporation and others.

5. Which region has the highest share in Absorbable Hemostats Market?

North America is expected to hold the highest share in the revenue in the Absorbable Hemostats market during the forecast period. The growing number of sports-related injuries and the rising number of spine-related disorders among others will also increase the absorbable hemostats market. Further, the rising adoption of Absorbable Hemostats in the country would result in the rising demand for treatments that make use of Absorbable Hemostats, which in turn would provide a conducive growth environment for the United States Absorbable Hemostats market as well as the North American region.

Table of Contents

1.Absorbable Hemostats Market Report Introduction

2.Absorbable Hemostats Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Absorbable Hemostats Market Key Factors Analysis

  • 4.1. Absorbable Hemostats Market Drivers
    • 4.1.1. Rising Incidence of Spinal Ailments
    • 4.1.2. Rising Focus on Blood Loss Management in Patients During Surgeries
    • 4.1.3. Technological Innovation in Product Development
  • 4.2. Absorbable Hemostats Market Restraints and Challenges
    • 4.2.1. The dearth of Skilled Professionals for Effective Use of Absorbable Hemostat Products
    • 4.2.2. High Cost of the Absorbable Hemostats
  • 4.3. Absorbable Hemostats Market Opportunities
    • 4.3.1. Rising Popularity of Biosurgical Absorbable Hemostat Product
    • 4.3.2. Targeting Emerging Markets for Product Launches

5. Absorbable Hemostats Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Absorbable Hemostats Market

7. Absorbable Hemostats Market Layout

  • 7.1. By Type
    • 7.1.1. Thrombin-Based Hemostats
    • 7.1.2. Oxidized Regenerated Cellulose-Based Hemostats
    • 7.1.3. Gelatin-Based Hemostats
    • 7.1.4. Collagen-Based Hemostats
    • 7.1.5. Others
  • 7.2. By Formulants
    • 7.2.1. Matrix & Gel Hemostats
    • 7.2.2. Sponge Hemostats
    • 7.2.3. Powder Hemostats
    • 7.2.4. Others
  • 7.3. By Application
    • 7.3.1. Neurosurgery
    • 7.3.2. Orthopedic Surgery
    • 7.3.3. General Surgery
    • 7.3.4. Reconstructive Surgery
    • 7.3.5. Others
  • 7.4. By End User
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. North America Absorbable Hemostats Market, by Type
      • 7.5.1.2. North America Absorbable Hemostats Market, by Formulants
      • 7.5.1.3. North America Absorbable Hemostats Market, by Application
      • 7.5.1.4. North America Absorbable Hemostats Market, by End User
      • 7.5.1.5. North America Absorbable Hemostats Market, by Country
      • 7.5.1.5.1. United States
      • 7.5.1.5.2. Canada
      • 7.5.1.5.3. Mexico
    • 7.5.2. Europe
      • 7.5.2.1. Europe Absorbable Hemostats Market, by Type
      • 7.5.2.2. Europe Absorbable Hemostats Market, by Formulants
      • 7.5.2.3. Europe Absorbable Hemostats Market, by Application
      • 7.5.2.4. Europe Absorbable Hemostats Market, by End User
      • 7.5.2.5. Europe Absorbable Hemostats Market, by Country
      • 7.5.2.5.1. France
      • 7.5.2.5.2. Germany
      • 7.5.2.5.3. United Kingdom
      • 7.5.2.5.4. Italy
      • 7.5.2.5.5. Spain
      • 7.5.2.5.6. Russia
      • 7.5.2.5.7. Rest of Europe
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. Asia-Pacific Absorbable Hemostats Market, by Type
      • 7.5.3.2. Asia-Pacific Absorbable Hemostats Market, by Formulants
      • 7.5.3.3. Asia-Pacific Absorbable Hemostats Market, by Application
      • 7.5.3.4. Asia-Pacific Absorbable Hemostats Market, by End User
      • 7.5.3.5. Asia-Pacific Absorbable Hemostats Market, by Country
      • 7.5.3.5.1. China
      • 7.5.3.5.2. Japan
      • 7.5.3.5.3. India
      • 7.5.3.5.4. Australia
      • 7.5.3.5.5. South Korea
      • 7.5.3.5.6. Rest of Asia Pacific
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. RoW Absorbable Hemostats Market, by Type
      • 7.5.4.2. RoW Absorbable Hemostats Market, by Formulants
      • 7.5.4.3. RoW Absorbable Hemostats Market, by Application
      • 7.5.4.4. RoW Absorbable Hemostats Market, by End User
      • 7.5.4.5. RoW Absorbable Hemostats Market, by Region
      • 7.5.4.5.1. Middle East
      • 7.5.4.5.2. Africa
      • 7.5.4.5.3. South America

8. Absorbable Hemostats Market Global Company Share Analysis - Key 3-5 Companies

9. Absorbable Hemostats Market Company and Product Profiles

  • 9.1. B.Braun
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Baxter
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Johnson & Johnson
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. BD
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Cura Medical
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. GELITA MEDICAL
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Curasan AG
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Meril Life Sciences
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Zhonghui Shengxi
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Beijing Datsing Bio-tech
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Guizhou Jin Jiu Biotech
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Beijing Taikesiman
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Foryou Medical
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Saikesaisi Holdings Group
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Biotemed
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Hangzhou Singclean Medical Products
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. Teleflex Incorporated
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Hemostasis, LLC
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Stryker
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Samyang Holdings Corporation
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Absorbable Hemostats Market in Global (2021-2030)
  • Table 4: Absorbable Hemostats Market in Global by Type (2021-2030)
  • Table 5: Absorbable Hemostats Market in Global by Formulants (2021-2030)
  • Table 6: Absorbable Hemostats Market in Global by Application (2021-2030)
  • Table 7: Absorbable Hemostats Market in Global by End User (2021-2030)
  • Table 8: Absorbable Hemostats Market in Global by Geography (2021-2030)
  • Table 9: Absorbable Hemostats Market in North America (2021-2030)
  • Table 10: Absorbable Hemostats Market in North America by Type (2021-2030)
  • Table 11: Absorbable Hemostats Market in North America by Formulants (2021-2030)
  • Table 12: Absorbable Hemostats Market in North America by Application (2021-2030)
  • Table 13: Absorbable Hemostats Market in North America by End User (2021-2030)
  • Table 14: Absorbable Hemostats Market in North America by Country (2021-2030)
  • Table 15: Absorbable Hemostats Market in the US (2021-2030)
  • Table 16: Absorbable Hemostats Market in Canada (2021-2030)
  • Table 17: Absorbable Hemostats Market in Mexico (2021-2030)
  • Table 18: Absorbable Hemostats Market in Europe (2021-2030)
  • Table 19: Absorbable Hemostats Market in Europe by Type (2021-2030)
  • Table 20: Absorbable Hemostats Market in Europe by Formulants (2021-2030)
  • Table 21: Absorbable Hemostats Market in Europe by Application (2021-2030)
  • Table 22: Absorbable Hemostats Market in Europe by End User (2021-2030)
  • Table 23: Absorbable Hemostats Market in Europe by Country (2021-2030)
  • Table 24: Absorbable Hemostats Market in France (2021-2030)
  • Table 25: Absorbable Hemostats Market in Germany (2021-2030)
  • Table 26: Absorbable Hemostats Market in the United Kingdom (2021-2030)
  • Table 27: Absorbable Hemostats Market in Italy (2021-2030)
  • Table 28: Absorbable Hemostats Market in Spain (2021-2030)
  • Table 29: Absorbable Hemostats Market in Russia (2021-2030)
  • Table 30: Absorbable Hemostats Market in Rest of Europe (2021-2030)
  • Table 31: Absorbable Hemostats Market in APAC (2021-2030)
  • Table 32: Absorbable Hemostats Market in APAC by Type (2021-2030)
  • Table 33: Absorbable Hemostats Market in APAC by Formulants (2021-2030)
  • Table 34: Absorbable Hemostats Market in APAC by Application (2021-2030)
  • Table 35: Absorbable Hemostats Market in APAC by End User (2021-2030)
  • Table 36: Absorbable Hemostats Market in APAC by Country (2021-2030)
  • Table 37: Absorbable Hemostats Market in China (2021-2030)
  • Table 38: Absorbable Hemostats Market in Japan (2021-2030)
  • Table 39: Absorbable Hemostats Market in India (2021-2030)
  • Table 40: Absorbable Hemostats Market in Australia (2021-2030)
  • Table 41: Absorbable Hemostats Market in South Korea (2021-2030)
  • Table 42: Absorbable Hemostats Market in Rest of APAC (2021-2030)
  • Table 43: Absorbable Hemostats Market in Rest of World (2021-2030)
  • Table 44: Absorbable Hemostats Market in RoW by Type (2021-2030)
  • Table 45: Absorbable Hemostats Market in RoW by Formulants (2021-2030)
  • Table 46: Absorbable Hemostats Market in RoW by Application (2021-2030)
  • Table 47: Absorbable Hemostats Market in RoW by End User (2021-2030)
  • Table 48: Absorbable Hemostats Market in RoW by Region (2021-2030)
  • Table 49: Absorbable Hemostats Market in Middle East (2021-2030)
  • Table 50: Absorbable Hemostats Market in Africa (2021-2030)
  • Table 51: Absorbable Hemostats Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Absorbable Hemostats Market in Global (2021-2030)
  • Figure 4: Absorbable Hemostats Market in Global by Type (2021-2030)
  • Figure 5: Absorbable Hemostats Market in Global by Formulants (2021-2030)
  • Figure 6: Absorbable Hemostats Market in Global by Application (2021-2030)
  • Figure 7: Absorbable Hemostats Market in Global by End User (2021-2030)
  • Figure 8: Absorbable Hemostats Market in Global by Geography (2021-2030)
  • Figure 9: Absorbable Hemostats Market in North America (2021-2030)
  • Figure 10: Absorbable Hemostats Market in North America by Type (2021-2030)
  • Figure 11: Absorbable Hemostats Market in North America by Formulants (2021-2030)
  • Figure 12: Absorbable Hemostats Market in North America by Application (2021-2030)
  • Figure 13: Absorbable Hemostats Market in North America by End User (2021-2030)
  • Figure 14: Absorbable Hemostats Market in North America by Country (2021-2030)
  • Figure 15: Absorbable Hemostats Market in the US (2021-2030)
  • Figure 16: Absorbable Hemostats Market in Canada (2021-2030)
  • Figure 17: Absorbable Hemostats Market in Mexico (2021-2030)
  • Figure 18: Absorbable Hemostats Market in Europe (2021-2030)
  • Figure 19: Absorbable Hemostats Market in Europe by Type (2021-2030)
  • Figure 20: Absorbable Hemostats Market in Europe by Formulants (2021-2030)
  • Figure 21: Absorbable Hemostats Market in Europe by Application (2021-2030)
  • Figure 22: Absorbable Hemostats Market in Europe by End User (2021-2030)
  • Figure 23: Absorbable Hemostats Market in Europe by Country (2021-2030)
  • Figure 24: Absorbable Hemostats Market in France (2021-2030)
  • Figure 25: Absorbable Hemostats Market in Germany (2021-2030)
  • Figure 26: Absorbable Hemostats Market in the United Kingdom (2021-2030)
  • Figure 27: Absorbable Hemostats Market in Italy (2021-2030)
  • Figure 28: Absorbable Hemostats Market in Spain (2021-2030)
  • Figure 29: Absorbable Hemostats Market in Russia (2021-2030)
  • Figure 30: Absorbable Hemostats Market in Rest of Europe (2021-2030)
  • Figure 31: Absorbable Hemostats Market in APAC (2021-2030)
  • Figure 32: Absorbable Hemostats Market in APAC by Type (2021-2030)
  • Figure 33: Absorbable Hemostats Market in APAC by Formulants (2021-2030)
  • Figure 34: Absorbable Hemostats Market in APAC by Application (2021-2030)
  • Figure 35: Absorbable Hemostats Market in APAC by End User (2021-2030)
  • Figure 36: Absorbable Hemostats Market in APAC by Country (2021-2030)
  • Figure 37: Absorbable Hemostats Market in China (2021-2030)
  • Figure 38: Absorbable Hemostats Market in Japan (2021-2030)
  • Figure 39: Absorbable Hemostats Market in India (2021-2030)
  • Figure 40: Absorbable Hemostats Market in Australia (2021-2030)
  • Figure 41: Absorbable Hemostats Market in South Korea (2021-2030)
  • Figure 42: Absorbable Hemostats Market in Rest of APAC (2021-2030)
  • Figure 43: Absorbable Hemostats Market in Rest of World (2021-2030)
  • Figure 44: Absorbable Hemostats Market in RoW by Type (2021-2030)
  • Figure 45: Absorbable Hemostats Market in RoW by Formulants (2021-2030)
  • Figure 46: Absorbable Hemostats Market in RoW by Application (2021-2030)
  • Figure 47: Absorbable Hemostats Market in RoW by End User (2021-2030)
  • Figure 48: Absorbable Hemostats Market in RoW by Region (2021-2030)
  • Figure 49: Absorbable Hemostats Market in Middle East (2021-2030)
  • Figure 50: Absorbable Hemostats Market in Africa (2021-2030)
  • Figure 51: Absorbable Hemostats Market in South America (2021-2030)
  • Figure 52: Market Drivers
  • Figure 53: Market Barriers
  • Figure 54: Marker Opportunities
  • Figure 55: PORTER'S Five Force Analysis